Seres Therapeutics Inc (MCRB)

May 21, 2026

MCRB SEC FilingsSeres Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 21, 2026

May 21, 2026

Seres Therapeutics (MCRB) Q1 2026 Miss: What Went WrongEPS Surprise History - Newser

May 21, 2026

May 20, 2026

MCRB News | SERES THERAPEUTICS INC (NASDAQ:MCRB) - ChartMill

May 20, 2026

May 19, 2026

MCRB: AI-driven microbiome therapeutics pipeline advances toward key clinical and commercial milestones - TradingView

May 19, 2026

May 19, 2026

Teresa L. Young sells shares; MCRB (NASDAQ: MCRB) files Form 144 notice - Stock Titan

May 19, 2026

May 19, 2026

Officer at Seres Therapeutics (NASDAQ: MCRB) sells 79 shares under 10b5-1 tax plan - Stock Titan

May 19, 2026

May 19, 2026

Seres Therapeutics (MCRB) officer sells shares after RSU vesting under 10b5-1 plan - Stock Titan

May 19, 2026

May 14, 2026

Seres Therapeutics stock (US81750R1023): Q1 2026 results and private placement - AD HOC NEWS

May 14, 2026

May 12, 2026

Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference - The Manila Times

May 12, 2026

May 12, 2026

How to watch Seres Therapeutics’ BioConnect investor presentation - Stock Titan

May 12, 2026

May 11, 2026

How Seres Therapeutics (MCRB) balances short term and long term focus | Q1 2026: EPS Misses ViewsNCAV - Newser

May 11, 2026

May 09, 2026

MSN Money - MSN

May 09, 2026

May 08, 2026

The working capital efficiency at Seres Therapeutics (MCRB) | Q1 2026: EPS Misses EstimatesProfit Margin - newser.com

May 08, 2026

May 06, 2026

CCORF Maintains Seres Therapeutics(MCRB.US) With Buy Rating, Maintains Target Price $22 - Moomoo

May 06, 2026

May 05, 2026

Seres Therapeutics 1Q 2026: Revenue $358K, EPS $(2.08) — 10-Q Summary - TradingView

May 05, 2026

May 05, 2026

Seres Therapeutics (NASDAQ: MCRB) Q1 2026 loss and going-concern risk - Stock Titan

May 05, 2026

May 05, 2026

Seres Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 05, 2026

May 05, 2026

Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times

May 05, 2026

May 05, 2026

Seres Therapeutics (Nasdaq: MCRB) Q1 2026 results and cash runway - Stock Titan

May 05, 2026

May 05, 2026

Seres awaits SER-155 data in weeks with cash through Q3 - Stock Titan

May 05, 2026

May 04, 2026

Seres presents preclinical data on IBD drug candidate SER-603 - Investing.com UK

May 04, 2026

May 04, 2026

Seres presents preclinical data on IBD drug candidate SER-603 By Investing.com - Investing.com South Africa

May 04, 2026

May 04, 2026

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease - The Manila Times

May 04, 2026

May 04, 2026

Experimental IBD microbiome therapy earns DDW poster honor - Stock Titan

May 04, 2026

May 04, 2026

Seres Therapeutics Presents Preclinical Data at Digestive - GlobeNewswire

May 04, 2026

May 01, 2026

Seres Therapeutics Inc expected to post a loss of $1.88 a shareEarnings Preview - TradingView

May 01, 2026

Apr 30, 2026

MCRB stock declines as Seres Therapeutics pauses SER-155 phase 2 study and shrinks headcount by 30% - MSN

Apr 30, 2026

Apr 29, 2026

Seres Therapeutics (MCRB) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Apr 29, 2026

Apr 27, 2026

Equity plan and director votes in Seres Therapeutics (NASDAQ: MCRB) 2026 proxy - Stock Titan

Apr 27, 2026

Apr 27, 2026

Microbiome Therapeutics Market is Going to Booming Growth - openPR.com

Apr 27, 2026

Apr 26, 2026

Chardan Capital Downgrades Seres Therapeutics (MCRB) - MSN

Apr 26, 2026

Apr 24, 2026

MCRB Price Today: Seres Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 22, 2026

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat

Apr 22, 2026

Apr 20, 2026

Seres Therapeutics (MCRB) Presents Key Data at ESCMID Congress - GuruFocus

Apr 20, 2026

Apr 20, 2026

Seres Therapeutics (MCRB) Showcases Research at ESCMID 2026 Cong - GuruFocus

Apr 20, 2026

Apr 20, 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 - The Manila Times

Apr 20, 2026

Apr 13, 2026

Microbiome Therapeutics Market Size, Share | Forecast [2034] - Fortune Business Insights

Apr 13, 2026

Apr 11, 2026

Aug Catalysts: Is Seres Therapeutics Inc impacted by rising rates2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Seres Therapeutics Stock Price Drops Below 50-Day Average - National Today

Apr 11, 2026

Apr 11, 2026

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat

Apr 11, 2026